CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
Two procedures for fractionating enzyme preparations on a column, somewhat different from the previously described chromatopile 1, have been found useful in preliminary tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results